Graham Fraser-Pye
Managing Director

Graham started his career in pharmaceuticals in 1992 with Allen and Hanbury’s (now part of GSK), where he held positions in Sales, Marketing and Commercial Information. In 1997 he was promoted to Marketing Manager and managed the established respiratory product portfolio worth in excess of £200M in the UK, of which his achievements include the launching of the first CFC free inhalers in the UK.

In 1999, Graham joined Dominion Pharma as the Head of Sales & Marketing. Following the acquisition of Dominion by Pliva, he was promoted to Managing Director and over the following 10 years was responsible for growing the newly named Pliva Pharma Ltd from £5m to £30m turnover. He also put the previously unknown Pliva name onto the map in the UK, and is credited with making the company a leading supplier of ethical medicines to the NHS. Graham set up Aspire Pharma in June 2009 and subsequently Aspire has grown into a real differentiated presence within the industry. Aspire Pharma is one of the fastest growing pharmaceutical companies in the UK today, adopting a sustainable customer focused strategy. Graham feels very strongly that there is a place in UK pharmaceuticals for a company like Aspire who can offer a differentiated service level to our customers, unparalleled expertise to our partners and a devoted team of individuals who together “make it happen”.